000			02001nas a22003495i 4500
001			1179-2000
003			DE-He213
005			20260610082520.0
007			cr nn 008mamaa
008			150723s||||||||sz uu poo|||||| b|EN |d
022			_a1179-2000
024	7		_a10.1007/40291.1179-2000 _2doi
210	1	0	_aMol Diagn Ther
245	1	0	_aMolecular Diagnosis & Therapy _h[electronic resource] / _cedited by Alison Fitches.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Adis.
300			_bonline resource.
520			_aMolecular Diagnosis & Therapy welcomes current opinion articles on emerging or contentious issues, comprehensive narrative reviews, systematic reviews (as outlined by the PRISMA statement), original research articles (including short communications) and letters to the editor. All manuscripts are subject to peer review by international experts. Topic coverage of the journal includes: Use of biomarkers to guide drug development and to serve as diagnostics or prognostic tools. Detection, monitoring, and treatment of molecular causes of disease. Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects, and/or disease progression. Drug/diagnostic combinations (theranostics). Emerging molecular diagnostic tools and technologies. Pathogen detection and drug resistance analysis. Ethical and regulatory issues relating to precision medicine. .
650		0	_aMedicine—Research.
650		0	_aBiology—Research.
650		0	_aMedical genetics.
650		0	_aCancer.
650		0	_aTherapeutics.
650	1	4	_aBiomedical Research.
650	2	4	_aMedical Genetics.
650	2	4	_aCancer Biology.
650	2	4	_aTherapeutics.
700	1		_aFitches, Alison. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1177-1062
856	4	0	_uhttps://doi.org/10.1007/40291.1179-2000 _zHybrid
999			_c3553 _d3553